These data suggest a role for the OXT/OXTR pathway in peripheral tissue inflammation, and the potential use of OXT, or OXTR agonists, for the treatment of inflammatory disorders related to obesity. The gene discussed is OXTR; the disease is obesity due to melanocortin 4 receptor deficiency.